Key distinctions include: GLP-1 therapies primarily reduce appetite support blood sugar regulation encourage gradual weight loss Retatrutide reduces appetite improves insulin sensitivity increases metabolic rate promotes fat oxidation may support lean muscle preservation This broader metabolic influence is why researchers believe triple-agonist peptides may represent the next evolution of medical weight management therapies
L.SehgalA
Among the options gaining attention are peptides for menopause, which may help balance hormone activity and reduce common discomforts
Acknowledgements Thanks to the US FDA for providing a free source of data for the study
Beesley VL, Webber K, Nagle CM, DeFazio A, Obermair A, Williams M, Friedlander M, Webb PM, OPAL Study Group (2020) When will I feel normal again
These products are strictly intended for in vitro laboratory research and analytical purposes when conducted by qualified research professionals in licensed facilities